Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

CHARCOAL, ACTIVATED, SUSPENSION

Awarded
SPE2DP26F7897Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded a delivery order under the basic contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of 3,000 bottles of activated charcoal suspension, identified by NSN 6505012828880 and NDC 66689-0203-08, at a total contract value of $45.39. The award, issued on July 21, 2026, is a fixed-price, one-time delivery with no variance allowed in quantity and is FOB destination, meaning the contractor assumes all transportation costs and risks until delivery at the specified location in Hampton, Virginia. The awardee is certified as a small, small disadvantaged, and women-owned business, triggering specific federal reporting obligations under FAR 19.13 and FAR 19.15. The item must be shipped via traceable means with parcel post strictly prohibited, and all packaging must be marked with the manufacturer’s CAGE code 1HT23 and the specified part number. Inspection and acceptance occur at the delivery point by government personnel, with no formal technical specifications or military standards cited beyond compliance with the basic contract and DLA unit-of-issue requirements. The contract contains no options, periods of performance beyond the single delivery date, or subcontracting requirements, reflecting a streamlined commercial item acquisition. The contracting officer is Lisa Quinn, with administrative support provided by Shairy M. Cartagena; no COR or COTR is assigned. Payment will be processed through the Defense Finance and Accounting Service at the Columbus, Ohio remittance address, using voucher-based submission consistent with DLA’s standard practices, likely via WAWF. The basic contract reference SPE2DX-25-D-9900 must be cited on all documentation, and DLA’s unit conversion tool must be used to ensure compliance with authorized procurement units. No preservation, barcoding, or detailed packaging specifications are outlined beyond traceable shipping and proper labeling.

General Info

DLA awards $45.39 contract to DMS PHARMACEUTICAL GROUP for activated charcoal suspension.

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

3

Delivery Order SPE2DP-26-F-7897 for Activated Charcoal Suspension

PDF, High priority: read this firstdelivery-order
High

Modification P00001 to Contract SPE2DP26F7897

PDF, High priority: read this firstmodification
High

SPE2DP26F7897 Unreadable Document

PDF, Low priorityother
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F7897 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $45.39 Award Date: 07-21-2026 Delivery order under: SPE2DX25D9900 Line items: - CHARCOAL, ACTIVATED, SUSPENSION (NSN/Part 6505012828880, PR 7017578656)

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
LORATADINE TABLETS
Solicitation # SPE2DP-27-T-0208
Solicitation SPE2DP-27-T-0208, issued by DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Loratadine 10 mg tablets (NSN 6505-01-524-9179). The requirement is for two bottles, with each bottle containing 500 tablets. The items are FDA-regulated and must be stored between 20° to 25° C and protected from excessive moisture. The product is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Delivery is required within 20 days after receipt of order, with terms set as FOB Destination and performance located at Camp Pendleton, California. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers in accordance with MIL-STD-2073-1E and special packaging instructions MPPWN00001. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and payment. The solicitation incorporates various federal regulations, including the Buy American Act, DFARS requirements for safeguarding covered defense information, and prohibitions on certain telecommunications equipment. Quotations are due by November 4, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS